NCT02857400
- Conditions
- Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Centre Hospitalier Auch Auch, France
- Hopital Rangueil Toulouse, France
- Institut Claudius Regaud Toulouse, France
Clinical trial condition
Metastatic Cancer
Explore clinical trials studying Metastatic Cancer. Study availability and eligibility vary by location and protocol.
430 public trials
83 recruiting studies
Metastatic Cancer trial results
NCT04050709
- Conditions
- Locally Advanced Solid Tumor, Metastatic Cancer, Neoplasm Metastasis, +5 more
- Locations
-
- Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
NCT05209880
- Conditions
- Cardiovascular Diseases, Chronic Disease, Chronic Kidney Disease Requiring Chronic Dialysis, +15 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT05665348
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
- Locations
-
- Chu Amiens Picardie Amiens, France
- CHU Angers, France
- Privé LES BONNETTES Arras, France
- Chu Avicienne Bobigny, France
NCT04991480
- Conditions
- Advanced Cancer, Breast Cancer, Breast Diseases, +10 more
- Locations
-
- Yale School of Medicine New Haven, Connecticut, United States
- Florida Cancer Specialists Orlando, Florida, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Oklahoma University Oklahoma City, Oklahoma, United States
NCT05276284
- Conditions
- Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- University Hospital of Copenhagen, Rigshospitalet Copenhagen, Denmark
NCT03510104
- Conditions
- Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
Completed
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor
NCT04648254
- Conditions
- Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +5 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Northwestern University Chicago, Illinois, United States
- Atlantic Health System Hospital Morristown, New Jersey, United States
Completed
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)
NCT05165433
- Conditions
- Carcinoma, Epithelial Tumor, Metastatic Cancer, +7 more
- Locations
-
- Providence Medical Foundation Santa Monica, California, United States
- UCLA Santa Monica, California, United States
- Moffitt-Advent Health Clinical Research Unit Celebration, Florida, United States
- Perelman Center of Advanced Medicine Philadelphia, Pennsylvania, United States
NCT03307785
- Conditions
- Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Encinitas, California, United States
- GSK Investigational Site San Marcos, California, United States
- GSK Investigational Site Sarasota, Florida, United States